Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy
Status:
Completed
Trial end date:
2004-06-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Voriconazole may be effective in preventing systemic fungal infections following
chemotherapy.
PURPOSE: Phase II trial to study the effectiveness of voriconazole in preventing systemic
fungal infections in children who have neutropenia after receiving chemotherapy for leukemia,
lymphoma, or aplastic anemia or in preparation for bone marrow or stem cell transplantation.